药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Estazolam
Ibrutinib
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Ibrutinib.
Estazolam
Blinatumomab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Blinatumomab.
Estazolam
Siltuximab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Siltuximab.
Estazolam
Vedolizumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Vedolizumab.
Estazolam
Secukinumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Secukinumab.
Estazolam
Fluprednidene
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluprednidene.
Estazolam
Obinutuzumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Obinutuzumab.
Estazolam
Pomalidomide
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Pomalidomide.
Estazolam
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Dimethyl fumarate.
Estazolam
Fluticasone furoate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Fluticasone furoate.
Estazolam
Certolizumab pegol
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Certolizumab pegol.
Estazolam
Ponatinib
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Ponatinib.
Estazolam
Carfilzomib
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Carfilzomib.
Estazolam
Teriflunomide
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Teriflunomide.
Estazolam
Belimumab
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Belimumab.
Estazolam
Ruxolitinib
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Ruxolitinib.
Estazolam
Eribulin
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Eribulin.
Estazolam
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Brentuximab vedotin.
Estazolam
Wortmannin
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Wortmannin.
Estazolam
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Pralatrexate.